In the latest trading session,, 0.42 million Generation Bio Co (NASDAQ:GBIO) shares changed hands as the company’s beta touched 2.66. With the company’s most recent per share price at $0.41 changed hands at -$0.03 or -5.96% at last look, the market valuation stands at $27.49M. GBIO’s current price is a discount, trading about -790.24% off its 52-week high of $3.65. The share price had its 52-week low at $0.32, which suggests the last value was 21.95% up since then.
Analysts gave the Generation Bio Co (GBIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended GBIO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Generation Bio Co (NASDAQ:GBIO) trade information
Instantly GBIO was in red as seen in intraday trades today. With action 6.63%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -61.32%, with the 5-day performance at 6.63% in the green. However, in the 30-day time frame, Generation Bio Co (NASDAQ:GBIO) is 13.95% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.30%. The 2025 estimates are for Generation Bio Co earnings to increase by 45.62%, but the outlook for the next 5-year period is at 24.37% per year.
GBIO Dividends
Generation Bio Co is expected to release its next quarterly earnings report in July.
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds the second largest percentage of outstanding shares, with 12.4628% or 8.28 million shares worth $23.35 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were T. Rowe Price New Horizons Fund, Inc. and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund . With 5.26 shares estimated at $2.17 million under it, the former controlled 7.85% of total outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund held about 2.65% of the shares, roughly 1.77 shares worth around $0.73 million.
